These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8416025)

  • 1. Serum homovanillic acid levels in schizophrenic patients and normal control subjects.
    Steinberg JL; Garver DL; Moeller FG; Raese JD; Orsulak PJ
    Psychiatry Res; 1993 Aug; 48(2):93-106. PubMed ID: 8416025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Free and conjugated plasma homovanillic acid in schizophrenic patients.
    Garcia A; Galinowski A; Guicheney P; Mignot E; Loo H; Meyer P
    Biol Psychiatry; 1989 May; 26(1):87-96. PubMed ID: 2720023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma homovanillic acid differences in clinical subgroups of first episode schizophrenic patients.
    Baeza I; Castro-Fornieles J; Deulofeu R; de la Serna E; Goti J; Salvà J; Bernardo M
    Psychiatry Res; 2009 Jul; 168(2):110-8. PubMed ID: 19501918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic antecedents of dopamine dysfunction in schizophrenia.
    Amin F; Silverman JM; Siever LJ; Smith CJ; Knott PJ; Davis KL
    Biol Psychiatry; 1999 May; 45(9):1143-50. PubMed ID: 10331106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma HVA in psychiatric patients: longitudinal studies.
    Javaid JI; Sharma RP; Janicak PG; Davis JM
    Psychopharmacol Bull; 1990; 26(3):361-5. PubMed ID: 2274637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal measurement of plasma homovanillic acid levels in schizophrenic patients. Correlation with psychosis and response to neuroleptic treatment.
    Pickar D; Labarca R; Doran AR; Wolkowitz OM; Roy A; Breier A; Linnoila M; Paul SM
    Arch Gen Psychiatry; 1986 Jul; 43(7):669-76. PubMed ID: 3718170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma homovanillic acid in neuroleptic responsive and nonresponsive schizophrenics.
    Duncan E; Wolkin A; Angrist B; Sanfilipo M; Wieland S; Cooper TB; Rotrosen J
    Biol Psychiatry; 1993 Oct; 34(8):523-8. PubMed ID: 8274579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of plasma homovanillic acid concentrations in schizophrenic patients and normal controls.
    Davidson M; Davis KL
    Arch Gen Psychiatry; 1988 Jun; 45(6):561-3. PubMed ID: 3377642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma prolactin and homovanillic acid as markers for psychopathology and abnormal movements during maintenance haloperidol treatment in male patients with schizophrenia.
    Newcomer JW; Riney SJ; Vinogradov S; Csernansky JG
    Psychiatry Res; 1992 Mar; 41(3):191-202. PubMed ID: 1594706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specificity of plasma HVA response to dexamethasone in psychotic depression.
    Wolkowitz OM; Doran A; Breier A; Roy A; Pickar D
    Psychiatry Res; 1989 Aug; 29(2):177-86. PubMed ID: 2798596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on concentrations of NA and HVA and activity of DBH in the serum from schizophrenic patients, first-degree relatives and normal subjects.
    Wei J; Ramchand CN; Hemmings GP
    Schizophr Res; 1992 Dec; 8(2):103-10. PubMed ID: 1360811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients.
    Szymanski S; Lieberman JA; Alvir JM; Mayerhoff D; Loebel A; Geisler S; Chakos M; Koreen A; Jody D; Kane J
    Am J Psychiatry; 1995 May; 152(5):698-703. PubMed ID: 7726309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of haloperidol on negative symptoms in drug-naive schizophrenic patients: effects on plasma homovanillic acid.
    Labarca R; Silva H; Jerez S; Ruiz A; Forray MI; Gysling K; Andres ME; Bustos G; Castillo Y; Hono J
    Schizophr Res; 1993 Mar; 9(1):29-34. PubMed ID: 8461269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychotic patients with increased plasma HVA and MHPG or increased HVA alone.
    Bowers MB
    Biol Psychiatry; 1993 Oct; 34(8):584-6. PubMed ID: 8274591
    [No Abstract]   [Full Text] [Related]  

  • 15. Longitudinal changes in symptoms and plasma homovanillic acid levels in chronically medicated schizophrenic patients.
    Suzuki E; Kanba S; Nibuya M; Adachi S; Sekiya U; Shintani F; Kinoshita N; Yagi G; Asai M
    Biol Psychiatry; 1994 Nov; 36(10):654-61. PubMed ID: 7880934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in plasma homovanillic acid concentrations in schizophrenic patients following neuroleptic discontinuation.
    Davidson M; Kahn RS; Powchik P; Warne P; Losonczy MF; Kaminsky R; Apter S; Jaff S; Davis KL
    Arch Gen Psychiatry; 1991 Jan; 48(1):73-6. PubMed ID: 1670618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of renal clearance on peripheral homovanillic acid measurements in healthy subjects and schizophrenic patients.
    Whelton CL; Gupta RN; Cleghorn JM; Ballagh SR
    Schizophr Res; 1993 Dec; 11(1):33-40. PubMed ID: 8297802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationships between serum brain-derived neurotrophic factor, plasma catecholamine metabolites, cytokines, cognitive function and clinical symptoms in Japanese patients with chronic schizophrenia treated with atypical antipsychotic monotherapy.
    Hori H; Yoshimura R; Katsuki A; Atake K; Igata R; Konishi Y; Nakamura J
    World J Biol Psychiatry; 2017 Aug; 18(5):401-408. PubMed ID: 27409727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma HVA, tardive dyskinesia and psychotic symptoms in long-term drug-free inpatients with schizophrenia.
    Muscettola G; Barbato G; de Bartolomeis A; Monteleone P; Pickar D
    Psychiatry Res; 1990 Sep; 33(3):259-67. PubMed ID: 2243901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma free homovanillic acid (HVA) as a predictor of clinical response in acute psychosis.
    Mazure CM; Nelson JC; Jatlow PI; Bowers MB
    Biol Psychiatry; 1991 Sep; 30(5):475-82. PubMed ID: 1932395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.